The use of intravenous immunoglobulin therapy in a tertiary pediatric hospital

References

1. ↵
   1. Prasad AN,
   2. Chaudhary S

   (2014) Intravenous immunoglobulin in pediatrics:a review. Med J Armed Forces India 70:277–280.

   OpenUrl
2. ↵
   1. Zülfikar B,
   2. Koç B

   (2014) Use of intravenous immunoglobulin in pediatric practice. Turk Pediatri Ars 49:282–288.

   OpenUrl
3. ↵
   1. Galal NM

   (2013) Pattern of intravenous immunoglobulins (IVIG) use in a pediatric intensive care facility in a resource limited setting. Afr Health Sci 13:261–265.

   OpenUrlPubMed
4. 1. Garcia-Lloret M,
   2. McGhee S,
   3. Chatila TA

   (2008) Immunoglobulin replacement therapy in children. Immunol Allergy Clin North Am 28:833–849.

   OpenUrlPubMed
5. ↵
   1. Perez EE,
   2. Orange JS,
   3. Bonilla F,
   4. Chinen J,
   5. Chinn IK,
   6. Dorsey M,
   7. et al.

   (2017) Update on the use of immunoglobulin in human disease:A review of evidence. J Allergy Clin Immunol 139:S1–S46.

   OpenUrlCrossRefPubMed
6. ↵
   1. Wong PH,
   2. White KM

   (2016) Impact of immunoglobulin therapy in pediatric disease:a review of immune mechanisms. Clin Rev Allergy Immunol 51:303–314.

   OpenUrl
7. ↵
   1. Guo Y,
   2. Tian X,
   3. Wang X,
   4. Xiao Z

   (2018) Adverse effects of immunoglobulin therapy. Front Immunol 9:1299.

   OpenUrl
8. 1. Pierce LR,
   2. Jain N

   (2003) associated with the use of intravenous immunoglobulin. Transfus Med Rev 17:241–251.

   OpenUrlCrossRefPubMedWeb of Science
9. 1. Cherin P,
   2. Marie I,
   3. Michallet M,
   4. Pelus E,
   5. Dantal J,
   6. Crave JC,
   7. et al.

   (2016) Management of adverse events in the treatment of patients with immunoglobulin therapy:a review of evidence. Autoimmun Rev 15:71–81.

   OpenUrl
10. ↵
    1. Akman AO,
    2. Kara FK,
    3. Koksal T,
    4. Cakir BC,
    5. Karagol C,
    6. Saylı T

    (2017) Association of hemolysis with high dose intravenous immunoglobulin therapy in pediatric patients:an open-label prospective trial. Transfus Apher Sci 56:531–534.

    OpenUrl
11. ↵
    1. Gayretli Aydın ZG,
    2. Tanır G

    (2017) Clinical indications of intravenous immunoglobulin use in Pediatric Infectious Diseases Clinic. J Pediatr Inf 11:e148–e153.

    OpenUrl
12. ↵
    1. Toh CC,
    2. Islahudin F,
    3. Adli A,
    4. Noraida Mohamed S

    (2018) Intravenous immunoglobulin therapy among pediatric patients:labeled and off-labeled indications. Braz J Pharm Sci 54:e0008.

    OpenUrl
13. ↵
    1. Jolles S,
    2. Sewell WA,
    3. Misbah SA

    (2005) Clinical uses of intravenous immunoglobulin. Clin Exp Immunol 142:1–11.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Anderson D,
    2. Ali K,
    3. Blanchette V,
    4. Brouwers M,
    5. Couban S,
    6. Radmoor P,
    7. et al.

    (2007) Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus Med Rev 21:S9–S56.

    OpenUrlCrossRefPubMed
15. ↵
    1. Hedrich CM,
    2. Schnabel A,
    3. Hospach T

    (2018) Kawasaki Disease. Front Pediatr 6:198.

    OpenUrl
16. ↵
    1. Oates-Whitehead RM,
    2. Baumer JH,
    3. Haines L,
    4. Love S,
    5. Maconochie IK,
    6. Gupta A,
    7. et al.

    (2003) Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev, CD004000.
17. ↵
    1. Gadian J,
    2. Kirk E,
    3. Holliday K,
    4. Lim M,
    5. Absoud M

    (2017) Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders. Dev Med Child Neurol 59:136–144.

    OpenUrl
18. ↵
    1. El-Nawawy A,
    2. El-Kinany H,
    3. Hamdy El-Sayed M,
    4. Boshra N

    (2005) Intravenous polyclonal immunoglobulin administration to sepsis syndrome patients:a prospective study in a pediatric intensive care unit. J Trop Pediatr 51:271–278.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    1. Prasad AN,
    2. Chaudhary S

    (2014) Intravenous immunoglobulin in children with acute myocarditis and/or early dilated cardiomyopathy. Indian Pediatr 51:583–584.

    OpenUrl
20. ↵
    1. Farinha IT,
    2. Miranda JO

    (2016) Myocarditis in paediatric patients:unveiling the progression to dilated cardiomyopathy and heart failure. J Cardiovasc Dev Dis 3:E31.

    OpenUrl
21. ↵
    1. Palabrica FR,
    2. Kwong SL,
    3. Padua FR

    (2013) Adverse events of intravenous immunoglobulin infusions:a ten-year retrospective study. Asia Pac Allergy 3:249–256.

    OpenUrlCrossRefPubMed